The stimulation of β3-adrenoceptor causes phosphorylation of extracellular signal-regulated kinases 1 and 2 through a G(s)- but not G(i)- dependent pathway in 3T3-L1 adipocytes

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 63-68

  Mizuno, Katsushige ^a   Kanda, Yasunari ^a   Kuroki, Yasutomi ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

CAMP dependent; MAP (mitogen activated protein) kinase cascade; Protein kinase; Regulation; Signal transduction

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLERA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

3T3 CELLS; ADIPOCYTES; ADRENERGIC AGONISTS; ANIMALS; CHOLERA TOXIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PERTUSSIS TOXIN; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA-3; VIRULENCE FACTORS, BORDETELLA;

EID: 0034666558     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00601-4     Document Type: Article

References (30)

1. s). Eur. J. Pharmacol. 188:1990;203-209.
2. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. U. S. A. 74:1997;3307-3311.
3. s. J. Biol. Chem. 264:1989;5352-5357.
4. i in rat adipocytes. Cell. Signalling. 6:1994;457-465.
5. 3-adrenergic receptor. Science. 245:1989;1118-1121.
6. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S., Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell Res. 253:1999;255-270.
7. 3-adrenergic receptor: new pharmacological profile and mechanism of activation. Mol. Pharmacol. 55:1999;255-262.
8. Green H., Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 7:1976;105-113.
9. 3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. J. Biol. Chem. 272:1997;17686-17693.
10. 3-adrenergic receptor. Mol. Pharmacol. 48:1995;492-498.
11. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsud M., Housman D.E., Graybiel A.M. A family of cAMP-binding proteins that directly activate Rap1. Science. 282:1998;2275-2279.
12. 3-Adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J. Biol. Chem. 274:1999;34795-34802.
13. 3-adrenergic receptors parallels lipolysis in rat adipocytes. Biochim. Biophys. Acta. 1992;349-352.
14. Mantzoros C.S., Qu D., Frederich R.C., Susulic V.S., Lowell B.B., Maratos-Flier E., Flie J.S. Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45:1996;909-914.
15. s). Biochem. J. 262:1989;643-649.
16. 3-adrenoceptor. Eur. J. Pharmacol. 385:1999;63-69.
17. 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 10:1991;3721-3727.
18. Sasaki T., Maehama T., Yamamoto T., Takasuga S., Hoshino S., Nishina H., Hazeki O., Katada T. Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts. J. Biochem. (Tokyo). 124:1998;934-939.
19. ras-dependent pathway. J. Biol. Chem. 274:1999;25833-25841.
20. 2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272:1997;5792-5799.
21. i-dependent mechanism. J. Biol. Chem. 274:1999;12017-12022.
22. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37:1997;421-450.
23. 3-adrenergic receptor agonist for treating obesity and diabetes. Bioorgan. Med. Chem. Lett. 9:1999;1921-1926.
24. 3-adrenergic receptor gene. J. Biol. Chem. 270:1995;29483-29492.
25. Van Corven E.J., Hordijik P.L., Medema R.H., Bos J.L., Moolenaar W.H. Pertussis toxin-sensitive activation of p21 ras by G protein-coupled receptor agonists in fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1257-1261.
26. Van Liefde I., Van Witzenburg A., Vauquelin G. Multiple beta adrenergic receptor subclasses mediate the L-isoproterenol-induced lipolytic response in rat adipocytes. J. Pharmacol. Exp. Ther. 262:1992;552-558.
27. Vaughan M., Pierce N.F., Greenough W.B. III Stimulation of glycerol production in fat cells by cholera toxin. Nature. 226:1970;658-659.
28. Vossler M.R., Yao H., York R.D., Pan M.-G., Rim C.S., Stork P.J.S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
29. s/mitogen-activated protein kinase pathway in mutant s49 cells. J. Biol. Chem. 273:1998;14533-14537.
30. 3-adrenoceptor agonists in humans. Diabetes. 47:1998;1555-1561.